
SimpliFASD
Health & Fitness
Free · Designed for iPad
With the decision tree, prescribers will be able to identify one of four clusters of symptoms with which to target treatment. "Clusters" include hyperarousal, emotional dysregulation, hyperactivity/neurocognitive, and cognitive inflexibility. Once the primary cluster with the greatest impact on patient functioning is known, then the algorithm decision tree identifies a first-line and second-line medication to prescribe. An adjunct therapy is also given for each cluster. Using the decision tree will help manage FASD/ND-PAE patients improve daily function and reduce unnecessary and unwanted medication. Four to six weeks after using the decision tree, prescribers can complete a brief survey to help evaluate the effectiveness of this first-ever medication decision tree for FASD/ND-PAE patients.
** This app integrates with the Health app **
Ratings & Reviews
This app has not received enough ratings or reviews to display an overview.
Improvements & bugfixes
The developer, Avicenna Research Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Linked to You
The following data may be collected and linked to your identity:
- Contact Info
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Diagnostics
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Avicenna Research Inc.
- Size
- 188.2 MB
- Category
- Health & Fitness
- Compatibility
Requires iOS 13.0 or later.
- iPhone
Requires iOS 13.0 or later. - iPad
Requires iPadOS 13.0 or later. - iPod touch
Requires iOS 13.0 or later. - Mac
Requires macOS 11.0 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- Languages
English and 12 more
- English, Catalan, Dutch, French, German, Italian, Persian, Slovenian, Spanish, Thai, Urdu, Vietnamese, Zulu
- Age Rating
4+
- 4+
- Copyright
- © Avicenna Research, Inc.